Entities / Company
Immuron.
small biotech company
- Reports this week
- 0
- Active events
- 1
- Connections
- 12
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Immuron this week
News at the entities that move Immuron most-
FDA StructuralFDA approved combination clearances for Elanco's Experior use on June 27, 2025.Moves Immuron
-
Nasdaq StructuralNasdaq maintains significant operational presence in countries including the Philippines, Lithuania, and Sweden.Moves Immuron
-
China Shared contextPoliticians, including Doug Burgum and John Fetterman, are proposing data center moratoriums in response to China's AI dominance.Moves Immuron
-
MarketBeat Mentioned togetherMarketBeat, Royal Bank of Canada, and Raymond James Financial updated their ratings and price targets for CT Real Estate Investment Trust.Moves Immuron
Connections
The 7 strongest of 12, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
Immuron's ability to proceed with its IND application is dependent on regulatory approval from the FDA.
-
Walter Reed Army Institute of Research Structural
Immuron and Walter Reed Army Institute of Research maintain a formal research agreement funded by the U.S. DoD.
-
Nasdaq Structural
Immuron is a publicly listed company on the Nasdaq stock exchange.
-
MarketBeat Mentioned together
MarketBeat tracks and provides consensus rating data for the company Immuron.
-
China Shared context
Immuron operates within the international market context of China.
-
Scientific Reports Transactional
Immuron published trial data in Scientific Reports.
-
Carlton Operational
The entities engaged in a meeting at Carlton's offices.